Investing in the future of medical research
We have committed over £1 million to fund life-changing research into degenerative diseases
Working with selected partners, our research grants fund PhD Studentships to carry out basic, clinical and epidemiological research projects that aim to improve knowledge, treatment and services.
As our population ages, demand on healthcare and social care services is growing, and our research grants are awarded in recognition of the increasing need for improved treatments and preventions.
Kidney Research UK
Kidney Research UK received a grant of £255,000 to fund three PhD studentships.
Corinna Brockhaus was awarded the Masonic Charitable Foundation PhD studentship at Leeds University. Corinna will be looking at kidney transplant rejection treatment through virus blocking.
BK virus harmlessly exists in a healthy person, but causes problems in some kidney transplant patients as the medicines taken to prevent transplant rejection allow the virus to grow uncontrollably. There are no effective treatments for BK infection, other than reducing the anti-rejection medications, which then means rejection is more likely. Drug-like compounds that prevent BK virus from getting into cells have been developed. This studentship project will study how these compounds work, use structural techniques to make new more effective compounds, and show whether blocking BK entry can prevent or treat BK virus kidney transplant damage.
Transplants are a key area of research, and the number one concern for patients. At the moment a transplant lasts around 10-15 years, and the main reason they fail is because the body rejects them. Corinna’s research is tackling a key piece in that puzzle as to why and how rejection happens, and combined with several other key projects we’re aiming to get to ‘one transplant for life’ for everyone who has a transplant.
"Having to have a kidney transplant carries many worries and uncertainties. Hopefully my research into new therapeutics against the BK polyomavirus will lead to future treatments. I hope this will lead to patients and their relatives having one less worry to deal with."
Alzheimer’s Research UK
Fight for Sight
Previous Medical Research Grants
Prior to our current focus on degenerative diseases we awarded grants to support medical research in many other areas, including those shown below.
Bowel and Cancer Research
Bowel & Cancer Research has been awarded £225,000. Over the next five years, this grant will fund three PhD studentships.
"Although 41,000 people every year are diagnosed with bowel cancer and more than 300,000 live with Inflammatory Bowel Disease, the area of bowel research remains woefully underfunded in relation to the burden of the disease. We have no doubt that the MCF grant to Bowel & Cancer Research will help to change that situation."
Chief Executive of Bowel & Cancer Research, Deborah Gilbert
Institute of Cancer Research
The Institute of Cancer Research received a grant of £143,400 to fund one PhD studentship to research cancer.
On 1 October 2018, Iona Black began her PhD studies at the Institute of Cancer Research. Over the next four years, Iona will aim to design chemical probes to help identify new drug targets on the cancer related protein Tankyrase. Iona is under the supervision of Professor Ian Collins and Dr Sebastian Guettler and will work across multi-disciplinary teams within the ICR’s Divisions of Cancer Therapeutics and Structural Biology.
The research will utilise a variety of structural biology and drug discovery techniques to identify and refine chemical compounds that target the particular region of the Tankyrase protein involved in a process known as scaffolding – this is a function of Tankyrase where two or more proteins are brought together in a stable structure. These compounds, known as chemical probes, will then be tested in cancer cell lines grown in the lab, to see what effect blocking the Tankyrase scaffolding functions has on cancer cells. This is a crucial early step towards the design of drugs that could one day be used in cancer patients where Tankyrase is involved.
For the next six to twelve months, Iona’s goal is to become fully competent and independent in the techniques she will use to target Tankyrase.
My first few months at the ICR have been intense but very exciting, as I realise how wide the field of drug discovery is. I look forward to seeing where this project leads me!